Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.
Cancer
; 128(15): 2967-2977, 2022 08 01.
Article
in En
| MEDLINE
| ID: mdl-35665495
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
Neuroblastoma
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Cancer
Year:
2022
Document type:
Article
Country of publication:
United States